FDA Approved: TOBI PODHALER — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for TOBI Podhaler (tobramycin) by Viatris Specialty LLC to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pseudomonas Aeruginosa Infection

Drugs mentioned

• TOBI Podhaler (tobramycin inhalation powder)

Snippet

SUPPL AP for TOBI PODHALER (TOBRAMYCIN)